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Relationship between Sleep-Disordered Breathing and
Blood Pressure Levels in Community-Based Samples 
of Japanese Men
Takeshi TANIGAWA, Naoko TACHIBANA＊, Kazumasa YAMAGISHI, Isao MURAKI, 
Minako KUDO, Tetsuya OHIRA＊, Akihiko KITAMURA＊, Shinichi SATO＊, 
Takashi SHIMAMOTO＊, and Hiroyasu ISO
To examine the relationship between sleep-disordered breathing (SDB) and blood pressure levels among
Japanese men, we conducted a population-based cross-sectional study of 1,424 men aged 40–69 years in
rural and urban communities. The 3% oxygen desaturation index (ODI) was selected as the indicator of SDB,
representing the number of desaturation events per hour of recording time in which blood oxygen fell by 
3% according to overnight pulse oximetry. To estimate the associations of 3% ODI levels with blood pres-
sure levels and hypertension, multiple linear regression and logistic regression analyses were performed.
The 3% ODI level was positively associated with systolic and diastolic blood pressure levels (SBP/DBP); a 5
event per hour increment of the 3% ODI level was associated with 0.8 mmHg (95% confidence interval [CI],
0.0–1.6) greater SBP and 0.7 mmHg (95% CI, 0.3–1.1) greater DBP after adjustment for age, body mass index,
ethanol intake, smoking category and community. The multivariate odds ratio of hypertension for the low vs.
high category of 3% ODI level was 1.63 (95% CI, 1.1–2.5). These associations were more evident among
overweight than non-overweight individuals. The significant association of nocturnal oxygen desaturation
with high blood pressure levels suggests that SDB plays a role in the development of hypertension among
Japanese men. (Hypertens Res 2004; 27: 479–484)
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studies with large sample sizes performed in Western coun-
tries have demonstrated a positive association between SDB
measured by polysomnography (PSG) and blood pressure
levels/hypertension, independent of age, obesity and other
confounding variables (5–8). Moreover, the Wisconsin
Sleep Cohort Study reported a dose-response association be-
tween SDB severity at baseline and the incidence of newly
diagnosed hypertension during a 4-year follow-up (9). This
causal relationship was also supported by a study employing
Introduction
Investigations of the relationship between sleep-disordered
breathing (SDB)—i.e., repetitive episodes of decreased or
arrested respiratory airflow during sleep—and hypertension
have mostly been limited to hospitalized patients (1, 2) or
have failed to fully account for possible confounding vari-
ables (3, 4). Recently, however, several population-based
an animal model (10). Based on these findings, the Seventh
Report of the Joint National Committee (JNC7) on preven-
tion, detection, evaluation, and treatment of high blood pres-
sure presented in the United States included sleep apnea as
the first disorder on the list of identifiable causes of hyper-
tension, and recommended a sleep study with O2 saturation
as a screening test (11).
To date, however, no community-based studies on the as-
sociation between SDB measured by physiological parame-
ters and blood pressure levels have been conducted in Asian
countries, probably due to the difficulty in using PSG in
community-based studies. Although the PSG is the gold
standard for monitoring SDB in a clinical setting, it is not a
practical approach for SDB screening for early detection and
treatment of severe SDB in a general population. In the pres-
ent population-based study of 1,424 Japanese men, we ex-
amined the association between nocturnal oxygen desatura-
tion and blood pressure levels using pulse oximetry.
Methods
Subjects
A research team made up of researchers from the Osaka
Medical Center for Health Science and Promotion and the
University of Tsukuba has conducted annual cardiovascular
risk surveys in an urban community of the district of Yao
City, a suburb of Osaka, since 1963; in the rural community
of Ikawa in northeast Japan since 1963; and in the rural com-
munity of Kyowa in central Japan since 1981 (12, 13). Re-
cently, a relationship between ankle-arm systolic blood pres-
sure (SBP) index and cardiovascular risk factors (14) and an
association between angiotensinogen 174M polymorphism
and high blood pressure, particularly among subjects with
higher sodium intake (15), have been reported based on data
from this cardiovascular risk survey.
Subjects for the present sleep investigation were recruited
from among participants in the above-described annual car-
diovascular surveys for the years 2000–2002. All recruited
subjects were Japanese men aged 40 to 69 years, and none
had been previously diagnosed with SDB. The numbers of
participants were 417 from the district of Yao City (recruit-
ment rate among the cardiovascular survey participants＝
89%), 298 from Ikawa (74%), and 709 from Kyowa (86%).
We restricted the subjects to men because men had a higher
priority to be examined due to a higher reported prevalence
of SDB in men than in women (16, 17). A total of 1,424
men, including 277 subjects using antihypertensive medica-
tion, were enrolled in the present study. For each subject,
physician epidemiologists and trained staff members ex-
plained the protocol in detail, and obtained informed con-
sent. The study protocol was approved by the Medical Ethics
Committee of the University of Tsukuba.
Measurement of Blood Pressure Levels and Con-
founding Variables
Arterial SBP and fifth-phase diastolic blood pressure (DBP)
were measured by physicians using a standard mercury
sphygmomanometer on the right arm while the subject was
quietly seated after an at least 5-min rest. Hypertension was
defined as SDB ≥160 mmHg, or DBP ≥100 mmHg and/or
use of antihypertensive medication. We measured several
potential confounders (13) that might also contribute to or
aggravate the incidence of SDB (17). Height in stocking feet
and weight in light clothing were measured, and body mass
index (BMI) was calculated as weight (kg)/height2 (m2). In-
terviews were conducted to determine the ethanol intake per
day, number of cigarettes smoked per day, and use of antihy-
pertensive medication. An interviewer assessed the usual
weekly alcohol intake in units of go, a traditional Japanese
unit of volume corresponding to 23 g ethanol, which was
converted to g of ethanol per day. One go is 180 ml of sake,
and corresponds to one bottle (633 ml) of beer, two single
shots (75 ml) of whiskey, or two glasses (180 ml) of wine.
Our previous study showed that alcohol intake was linearly
associated with changes in SBP and DBP (18). Persons who
smoked one or more cigarettes/day were defined as current
smokers.
Assessment of SDB
A pulse-oximeter PULSOX-3Si (Minolta Co., Osaka, Japan)
was attached to the left wrist during one night of sleep at
home. The sensor probe was fitted to the fourth finger and
secured with tape by each subject. The internal memory of
this device stores the values of blood oxygen saturation by
performing a moving average for the last 5 s, updated every
second; this sampling time was short enough to avoid under-
estimation of oxygen desaturation (19). Data were down-
loaded to a personal computer via an interface (PULSOX
IF-3; Minolta) and analyzed using proprietary software sup-
plied with the equipment (DS-3 ver. 2.0a; Minolta). We used
the value of oxygen desaturation per hour (oxygen desatura-
tion index, ODI) as an indicator of SDB. A 3% ODI was se-
lected as an index of oxygen desaturation, representing the
number of events per hour of recording time in which blood
oxygen fell by ≥3%. The 3% ODI during the estimated sleep
time of more than 4 h computed for each subject was used
for the analysis. Since the duration of sleep estimated by
pulse oximetry is often longer than the true total sleep time,
we had subjects fill out a sleep diary in order to exclude the
waking time from the analysis and thereby minimize poten-
tial overestimation of the sleep duration. The criteria for
SDB were defined by 3% ODI level as 5 and 15 events per
hour, corresponding to mild and moderate-to-severe SDB,
respectively.
Nakamata et al. previously reported that the validity of the
pulse oximetry by synchronous overnight recording of both
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PULSOX-3Si and standard PSG among 256 consecutive pa-
tients (mean BMI, 26.8 kg/m2) who had been referred to a
sleep-disordered breathing center: 80% sensitivity and 95%
specificity for detecting an apnea-hypopnea index (AHI) of
≥5 by PSG using a cut-off threshold of 3% ODI＝5, and
85% sensitivity and 100% specificity for detecting an AHI of
≥20 by 3% ODI＝15 (20). To examine the reproducibility of
pulse oximetry, two overnight pulse oximetry measurements
were conducted in 61 men who had no habit of alcohol in-
take. The median values of 3% ODI on the first and the sec-
ond nights were 5.4 and 4.8 per hour, respectively ( p＝0.95,
Wilcoxon’s signed-rank test). Spearman’s rank correlation
coefficient was 0.81( p<0.0001).
Statistical Analysis
Age-adjusted mean values of BMI, ethanol intake, and blood
pressure levels and age-adjusted prevalence of current smok-
ing, antihypertensive medication use and hypertension were
calculated according to the categories of nocturnal oxygen
desaturation levels (3% ODI: <5, 5–14, ≥15) using analysis
of covariance and the χ2 test, and a linear trend was tested
using median variables of the nocturnal oxygen desaturation
categories. A predicted difference associated with a 5 event
per hour increment of the 3% ODI level was calculated by
multiple linear regression analysis to estimate the indepen-
dent associations of the nocturnal oxygen desaturation levels
with blood pressure levels, while adjusting for the potentially
confounding variables of age, BMI, ethanol intake, smoking
category (never-smokers, ex-smokers, current smokers), and
community. A logistic regression analysis was performed to
estimate the independent associations of the nocturnal oxy-
gen desaturation levels with hypertension, adjusting for these
confounding variables. A linear trend of blood pressure lev-
els and hypertension with nocturnal oxygen desaturation lev-
els was tested using median variables of the nocturnal oxy-
gen desaturation categories. The analyses were also per-
formed using a stratification by age (40 to 64 and 65 to 69
years) and BMI (<25 and ≥25 kg/m2). The interactions of
3% ODI levels with age and overweight in relation to the
prevalence of hypertension were examined using cross-prod-
uct terms.
All statistical analyses were performed using SAS version
8.02 software (SAS Institute Inc., Cary, USA). All probabili-
ty values for statistical tests were two-tailed, and values of
p<0.05 were regarded as statistically significant.
Results
The mean values and prevalences of selected cardiovascular
risk characteristics among total subjects were 58.6 (SD, 7.7)
years for age, 24.0 (2.9) kg/m2 for BMI, 6.1 (7.1) per hour
for 3% ODI, 133 (17) mmHg for SBP and 82 (10) mmHg for
DBP, 73% for ethanol intake, 42% for current smoking, 19%
for use of antihypertensive medication, and 25% for hyper-
tension.
Table 1 shows the age-adjusted mean values and preva-
lence of risk characteristics according to the categories of
nocturnal ODI levels. There were positive associations of
3% ODI levels with BMI, ethanol intake, blood pressure lev-
els, antihypertensive medication use and hypertension, but
an inverse association with current smoking.
Table 2 shows the age- and multivariate-adjusted blood
pressure levels according to categories of 3% ODI levels,
and predicted differences in blood pressure levels associated
with a 5 event per hour increment of the 3% ODI level
among 1,147 men who were not on antihypertensive medica-
tion. There were positive associations of 3% ODI levels with
SBP and DBP after adjustment for age, and also again after
further adjustment for other confounding variables. The pre-
dicted differences associated with a 5 event per hour incre-
ment of the 3% ODI level for SBP and DBP were 0.8 mmHg
(95% confidence interval [CI], 0.0–1.6) and 0.7 mmHg (95%
CI, 0.3–1.1), respectively.
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＊Hypertension was defined as systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg and/or use of antihyperten-
sive medication. BMI, body mass index. N, number of subjects.
Table 1. Age-Adjusted Means (SEM) and Prevalence of Selected Cardiovascular Risk Characteristics According to 3%
Oxygen Desaturation Index (ODI) Levels
3% ODI
p for trend
0–4 5–14 ≥15
N 848 448 128
Age (year) 58.1 (0.3) 58.9 (0.4) 60.3 (0.7) 0.002
BMI (kg/m2) 23.1 (0.1) 25.0 (0.1) 26.3 (0.2) <0.0001
Current ethanol intake (g/day) 22.1 (0.8) 24.8 (1.1) 27.7 (2.1) 0.02
Current smokers (%) 44 39 32 0.004
Systolic blood pressure (mmHg) 130.9 (0.6) 133.5 (0.8) 139.9 (1.5) <0.0001
Diastolic blood pressure (mmHg) 80.8 (0.4) 83.1 (0.5) 85.8 (0.9) <0.0001
Use of antihypertensive medication (%) 17 22 31 <0.0001
Hypertension (%)＊ 21 28 41 <0.0001
The prevalence of hypertension, when including men who
were on antihypertensive medication, also increased with
greater 3% ODI levels (Table 3). The multivariate odds ratio
of hypertension was 1.63 (95% CI, 1.07–2.50) in the low vs.
high categories of the 3% ODI level. The relations between
3% ODI levels and hypertension did not vary between mid-
dle-aged (40 to 64 years) and elderly (≥65 years) subjects:
1.61 (95% CI, 0.94–2.76) vs. 1.67 (95% CI, 0.82–3.41). The
association tended to be more evident among overweight
than among non-overweight subjects: 1.96 (95% CI, 1.09–
3.52) vs. 1.28 (95% CI, 0.65–2.52), although the interaction
did not reach the level of statistical significance.
Discussion
We found a significant association between SDB severity
measured by ODI and blood pressure levels among middle-
aged Japanese men, independent of age, BMI, ethanol in-
take, and smoking status. Our results are consistent with the
recent findings from the United States and Europe (5–8), and
confirm the SDB-blood pressure associations among Asian
populations. Furthermore, the relationship between SDB and
hypertension was more obvious among overweight men than
among non-overweight men, suggesting that SDB and over-
weight may synergistically enhance a rise in blood pressure
levels.
SDB and hypertension share common risk factors, such as
male gender, obesity and ethanol intake (17). In earlier stud-
ies, the independent relationship observed between SDB and
hypertension was controversial because the potentially con-
founding factors of age and obesity were not accounted for
(2, 3). Recent large cross-sectional studies have shown a
positive association between polysomnographically assessed
AHI and daytime hypertension with adjustment for con-
founding variables (5–8).
The causal relationship between SDB and hypertension
has been supported by both epidemiological and animal ex-
perimental studies. A 4-year follow-up study reported the
relative risk of incident hypertension as 2.89 (95% CI,
1.46–5.64) among subjects with AHI ≥15 compared with
subjects with AHI＝ 0 (9). An animal experiment using a 
canine model demonstrated that daytime blood pressure in-
creased after experimentally induced intermittent airway oc-
clusion during nocturnal sleep and fell after a nighttime sleep
with quiet breathing (10). Furthermore, two randomized clin-
ical trials of continuous positive airway pressure intervention
have demonstrated a significant reduction of nighttime and
daytime blood pressure levels in hypertensive patients with
obstructive sleep apnea (21, 22).
The biological mechanisms that link SDB to daytime ele-
vation of blood pressure levels seem to be multifactorial, and
probable mechanisms include high sympathetic nerve activi-
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＊Adjusted for age, body mass index, ethanol intake, smoking status, and community. N, number of subjects.
Table 2. Age-Adjusted and Multivariate-Adjusted Means (SEM) of Systolic and Diastolic Blood Pressure According to
Categories of 3% Oxygen Desaturation Index (ODI) Level, and Predicted Differences (SEM) in Blood Pressure Levels
Associated with 5 per Hour Increment of 3% ODI among 1,147 Subjects without Use of Antihypertensive Medication
3% ODI
p for trend
3% ODI
0–4 5–14 ≥15 Predicted difference p value(SEM)
N 711 350 86
Systolic blood pressure
Age-adjusted means (mmHg) 128.9 (0.6) 131.6 (0.9) 137.9 (1.7) <0.0001 1.7 (0.4) <0.0001
Multivariate adjusted means＊ (mmHg) 129.8 (0.6) 130.4 (0.9) 135.1 (1.7) 0.008 0.8 (0.4) 0.05
Diastolic blood pressure
Age-adjusted means (mmHg) 80.1 (0.4) 82.6 (0.5) 86.2 (1.1) <0.0001 1.4 (0.2) <0.0001
Multivariate adjusted means＊ (mmHg) 80.8 (0.4) 81.6 (0.5) 84.2 (1.1) 0.004 0.7 (0.2) 0.004
＊Adjusted for age, body mass index (BMI), ethanol intake, smoking status, and community. N, number of subjects.
Table 3. Odds Ratios＊ and 95% Confidence Intervals of Hypertension According to 3% Oxygen Desaturation Index (ODI) Levels
N
3% ODI
p for trend
0–4 5–14 ≥15
All subjects 1,424 1.00 1.12   (0.84, 1.49) 1.63   (1.07, 2.50) 0.01
BMI <25 kg/m2 929 1.00 0.94   (0.63, 1.40) 1.28   (0.65, 2.52) 0.46
BMI ≥25 kg/m2 495 1.00 1.36   (0.88, 2.13) 1.96   (1.09, 3.52) 0.02
Age <65 years 1,017 1.00 1.15   (0.80, 1.65) 1.61   (0.94, 2.76) 0.04
Age ≥65 years 407 1.00 1.09   (0.67, 1.76) 1.67   (0.82, 3.41) 0.11
ty observed even when awake in patients with obstructive
sleep apnea, which is attenuated by treatment with continu-
ous positive airway pressure (23), increased circulating cate-
cholamine levels associated with sympathetic nerve activity
(24), enhanced vasoconstrictor sensitivity partly due to vas-
cular remodeling by nocturnal blood pressure surges (25),
and enhanced insulin resistance that is rapidly improved by
treatment with continuous positive airway pressure (26).
The strengths of the present study are the use of a large
community-based sample and the evaluation of SDB status
during sleep at home, which has the advantage of providing
a more realistic estimation of severity of SDB compared
with hospital/laboratory studies because of the maintenance
of regular daily habits of sleep, physical activity, diet and
ethanol intake in a general population.
There are several limitations in the present study. First,
because we used only a single blood pressure measurement
for the analyses, the measurement variability may have
weakened the SDB-blood pressure association. However, the
large number of subjects in our study allowed the attainment
of sufficient statistical power to detect the associations. Sec-
ond, pulse oximetry inherently underestimates respiratory
disturbance events during sleep compared with full-PSG,
particularly in a non-obese population such as that studied
here (mean BMI, 24.0 kg/m2). The sensitivity of detection of
apneic/hypopneic events ≥5/h by PSG has been reported to
be 68% among subjects with BMI ≤27.0 kg/m2 and 94%
among those with higher BMI (20). The reasons for the low-
er sensitivity by pulse oximetry among lean subjects have
been considered to include the functional reserve of lung
volume sufficient to maintain normal blood oxygen levels,
and difficulty in detecting hypopneic events that do not cause
oxygen desaturation. Third, the recording time modified by
self-report was regarded as the total sleep time in this study,
and this value may have been longer than the real sleep time
obtained only by PSG using the electroencephalogram. In
any case however, these limitations would be expected to
lead to an underestimation rather than an overestimation of
the association between SDB and blood pressure levels.
Lastly, potential dietary confounding variables such as sodi-
um intake were not taken into account. However, there is no
evidence of an association between SDB and sodium intake.
Multiple regression analysis showed that a 5 event per
hour increment of the 3% ODI level corresponded to a
0.8 mmHg and 0.7 mmHg elevation of SBP and DBP, re-
spectively. These differences in blood pressure levels seem
to be small from the clinical point of view. However, even a
small reduction in blood pressure levels has an important
public health impact on cardiovascular morbidity and mor-
tality. A meta-analysis of nine prospective studies demon-
strated that a long-term difference of 5 mmHg in mean DBP
was associated with a 34% reduction in risk of stroke and a
21% reduction in risk of coronary heart disease (27). In our
previous study of Japanese, a difference of 5 mmHg in mean
SBP was associated with 15% and 10% reductions of these
diseases, respectively (28). Therefore, the promotion of
screening and treatment for undiagnosed SDB among popu-
lations in Japan may have a substantial impact on the pre-
vention of cardiovascular disease.
In conclusion, the significant association of SDB with
blood pressure levels suggests that SDB plays a role in the
development of hypertension. Follow-up studies and clinical
trials will be needed to examine the causal relationship be-
tween SDB and hypertension, and to explore the effect of the
control of SDB on blood pressure reduction.
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